Anti-saccbaromyces cerevisiae as unusual antibodies in auto immune hepatitis

Minerva Gastroenterologica e Dietologica

Volumn 55, Issue 1, 2009, Pages 37-40

  Fagoonee, S ^a   Luca, L De ^b   Angelis, C De ^c   Castelli, A ^c   Rizzetto, M ^c   Pellicano, R ^c,d  

^a UNIVERSITY OF TURIN   (Italy)

^b Pellegrini Hospital   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

^d Department of Gastro Hepatology ^*  (Italy)

Author keywords

Autoantibodies; autoimmune; Hepatitis; Liver cirrhosis; Saccharomyces cerevisiae

Indexed keywords

ANTI SACCHAROMYCES CEREVISIAE ANTIBODY; AUTOANTIBODY; AZATHIOPRINE; IMMUNOGLOBULIN G; PREDNISONE; UNCLASSIFIED DRUG; ANTIBODY;

ANTIBODY BLOOD LEVEL; AUTOIMMUNE HEPATITIS; CELIAC DISEASE; CROHN DISEASE; DISEASE MARKER; GENETIC PREDISPOSITION; HUMAN; IMMUNOREACTIVITY; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; REVIEW; SACCHAROMYCES CEREVISIAE; SCLEROSING CHOLANGITIS; ULCERATIVE COLITIS; BLOOD; IMMUNOLOGY;

ANTIBODIES; HEPATITIS, AUTOIMMUNE; HUMANS; SACCHAROMYCES CEREVISIAE;

EID: 67649337109     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Durazzo M, Premoli A, Morello E. Epatite autoimmune. Conoscenze attuali. Minerva Med 2004;95:l-9. 9.
2. Boberg KM. Prevalence and epidemiology of autoimmune hepatitis. Clin Liver Dis 2002;6:635-47.
3. Berlin T, Zandman-Goddard G, Blank M, Matthias T, Pfeiffer S, Weis I et al. Autoantibodies in nonautoim-mune individuals during infections. Ann NY Acad Sci 10. 2007;1108:584-93.
4. Czaja A, Freese DK. AASLD Practice Guidelines. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002;36:480-97.
5. Medina J, Garcia-Buey L, Moreno-Otero R. Review article: immunopathogenetic and therapeutic aspects of autoimmune hepatitis. Aliment Pharmacol Ther 2003;17:l-l6.
6. Czaja AJ. Progress in the diagnosis and treatment of autoimmune hepatitis. Minerva Med 2008;99:549-68.
7. Ben-Ari Z, Czaja AJ. Autoimmune hepatitis and its vari- 13. ant syndrome. Gut 2001;49:589-94.
8. Simondi D, Mengozzi G, Betteto S, Bonardi R, Ghignone RP, Fagoonee S et al. Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease. Inflamm Bowel Dis 2008;14:645-51.
9. Vermeire S, Joossens S, Peeters M, Monsuur F. Marien G, Bossuyt X et al. Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. Gastroenterology 2001;120:827-33.
10. Czaja AJ, Shums Z, Donaldson PT, Norman GL. Frequency and significance of antibodies to Saccha-romyces cerevisiae in autoimmune hepatitis. Dig Dis Sci 2004;49:6ll-8.
11. Muratori P, Muratori L, Guidi M, Maccariello S. Pappas G, Ferrari R et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol 2003;132:473-6.
12. Reddy KR, Colombel JF, Poulain D, Krawitt EL. Anti-Saccharomyces cerevisiae antibodies in autoimmune liver disease. Am J Gastroenterol 2001:96:252-3.
13. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006;131:1981-2002.